Navigation Links
Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
Date:8/26/2010

risks and uncertainties include, without limitation, the capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the ability to achieve commercialization in India as a result of the proposed treatment program at Medanta, The Medicity Institute, whether successful or not,  the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.Contacts:James A. JoyceChairman, CEO858.459.7800 x301jj@aethlonmedical.comJohn P. SalvadorDirector, Communications & Investor Relations858.459.7800 x307jps@aethlonmedical.comJon CunninghamRedChip Companies, Inc.800.733.2447 x107jon@redchip.com
'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... QPID Health , a leader in clinical intelligence software, today ... and their first West Coast location in San ... in Boston , and will house product development, ... Southern California office will be located at 1000 ... demands of customers nationwide.  Both new locations will be operational ...
(Date:9/16/2014)... 16, 2014   Evana Automation Specialists , a ... and test systems, recently received a contract to provide ... manufacturer. The Evana solution will help error-proof the process ... well as reduce labor. A catheter ... robotic assembly cell. The robot will pick the adapter, ...
(Date:9/16/2014)... ORLANDO, Fla. , Sept. 16, 2014   ... standard in the patient experience at hospitals. The myComfort™ ... , Vestagen,s active barrier fabric that is fluid repellant, ... shown to inhibit the growth of bacteria on the ... the role clothing plays in the chain of transmission. ...
Breaking Medicine Technology:QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2
... (OTC Bulletin Board: ACUR) (the "Company") today announced ... "Agreement"), with an,investor group comprised of Vivo Ventures ... L.P., GCE Holdings LLC and certain individual investors,(the ... Units ("Units") at a price of $1.08 per ...
... 20 Ranbaxy Pharmaceuticals Inc.,(RPI), a wholly owned ... RLL has received approval from the U.S. Food ... and,Acetaminophen Tablets USP, 7.5 mg/750 mg, 10 mg/500 ... The Office of Generic Drugs, U.S. Food and ...
Cached Medicine Technology:Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 2Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 3Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP 2
(Date:9/16/2014)... 16, 2014 CarePoint Health is ... Leigh Montes, MD, has joined our expanded Bariatric ... Hospital. Our system welcomes Dr. Montes to the ... surgical weight loss center, helps patients achieve long-term ... surgery procedures, including Gastric Sleeve, Gastric Bypass, LAP-BAND ...
(Date:9/16/2014)... HealthDay Reporter MONDAY, Sept. 15, 2014 ... can delay a man,s onset of age-related high blood pressure ... pressure naturally increases as people grow older and their arteries ... don,t start drifting toward high blood pressure until their mid-50s. ... early signs of high blood pressure in their mid-40s, researchers ...
(Date:9/16/2014)... discoveries everyday, but that doesn,t mean the findings are ... example, the neonatal mortality rate is 10 times higher ... that applying an inexpensive topical solution of chlorhexidine to ... rate by 24 percent, many Indian parents did not ... not that we don,t have solutions to solve major ...
(Date:9/16/2014)... The Columbia University College of Dental Medicine ... in Diversity (HEED) award from INSIGHT Into Diversity ... higher education. As a recipient of the annual ... universities that demonstrate an outstanding commitment to diversity ... other recipients in INSIGHT Into Diversity magazine,s November ...
(Date:9/16/2014)... Size is relative, especially to people who tend to ... University Medical Center in the US found that seven ... weighs. People of normal weight make this mistake much ... tend to misjudge their children,s size, as youngsters misjudge ... now at Weill-Cornell Medical College, in a study in ...
Breaking Medicine News(10 mins):Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3Health News:Blood Pressure Seems to Stay Lower Longer in Fitter Men 2Health News:Blood Pressure Seems to Stay Lower Longer in Fitter Men 3Health News:Pairing social networks with social motives to close the science gap 2Health News:Pairing social networks with social motives to close the science gap 3Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4Health News:Poor body size judgement can lead to increased tolerance of obesity 2
... , MONDAY, March 21 (HealthDay News) -- A woman,s use ... risk of respiratory problems in her children, according to a ... use of birth control pills may increase the risk of ... said the authors of the new study. The researchers ...
... MONDAY, March 21 (HealthDay News) -- While the majority of ... generally satisfied years later, almost 40 percent are saddled with ... removed, a small, new Belgian study reveals. The finding ... the University of California, San Francisco that suggested gastric bypass ...
... Rockville, Md., March 21, 2011 As part of ... Pharmacopeial Convention (USP) is working with the Food and ... (CHPA) to update quality standards for widely used medicines ... an ambitious, long-term effort to assess written (or documentary) ...
... Health Sciences University is enrolling patients in a federally funded ... progression of kidney disease. "The question is, if you ... said Dr. Laura Mulloy, Chief of the GHSU Section of ... Intervention Trial, or SPRINT, funded by the National Institutes of ...
... change the balance of bacteria that naturally live in the ... Brain, Behavior, and Immunity . "These bacteria ... the immune response," said lead researcher Michael Bailey. ... number of gut microorganisms, according to scientists from The Ohio ...
... March, 2011 Alcohol use during pregnancy is common ... and development of exposed offspring. Despite warnings from the ... contemplating pregnancy, a recent survey by the National Birth ... drank alcohol at some time during their pregnancy, with ...
Cached Medicine News:Health News:Moms' Use of 'the Pill' Won't Raise Kids' Asthma Risk: Study 2Health News:40% of Gastric Banding Patients Have Complications 2Health News:40% of Gastric Banding Patients Have Complications 3Health News:40% of Gastric Banding Patients Have Complications 4Health News:Quality standards for widely used medicines strengthened 2Health News:Quality standards for widely used medicines strengthened 3Health News:Study examines whether lower blood pressure reduces kidney disease progression 2Health News:Adolescent offspring of women who drank alcohol during first trimester 2
... Battery Powered Orthopedic Systems., ,The PowerPro® ... to the Hall® Surgical line of powered ... the first and only software controlled battery ... is a full-function orthopedic power system specifically ...
... Brasseler USAs Large Bone Power System is ... new technological advancements. The truly innovative design ... pack, which is comprised of the battery, ... contains only mechanical components, which provides a ...
... is a type I collagen implant designed ... or loss of meniscus tissue, typically through ... purpose of the CMI is to assist ... a more vigorous lifestyle, while forestalling or ...
... OBIs proprietary PolyGraft® material technology which ... that is both biologically friendly and ... of polylactide-co-glycolide, calcium sulfate and polyglycolide ... fabricated into products such as granules, ...
Medicine Products: